Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing F Ducimetière, A Lurkin, D Ranchère-Vince, AV Decouvelaere, M Péoc'h, ... PloS one 6 (8), e20294, 2011 | 653 | 2011 |
Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study A Italiano, I Di Mauro, J Rapp, G Pierron, N Auger, L Alberti, F Chibon, ... The Lancet Oncology 17 (4), 532-538, 2016 | 206 | 2016 |
Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis D Arpin, D Perol, JY Blay, L Falchero, L Claude, S Vuillermoz-Blas, ... Journal of clinical oncology 23 (34), 8748-8756, 2005 | 200 | 2005 |
Micro‐RNA profiles in osteosarcoma as a predictive tool for ifosfamide response A Gougelet, D Pissaloux, A Besse, J Perez, A Duc, A Dutour, JY Blay, ... International journal of cancer 129 (3), 680-690, 2011 | 166 | 2011 |
Desmoplastic small round cell tumor: current management and recent findings A Dufresne, P Cassier, L Couraud, P Marec-Bérard, P Meeus, L Alberti, ... Sarcoma 2012 (1), 714986, 2012 | 134 | 2012 |
Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas I Asmane, E Watkin, L Alberti, A Duc, P Marec-Berard, I Ray-Coquard, ... European Journal of Cancer 48 (16), 3027-3035, 2012 | 131 | 2012 |
Assay of hydroxyl radicals generated by focused ultrasound L Villeneuve, L Alberti, JP Steghens, JM Lancelin, JL Mestas Ultrasonics sonochemistry 16 (3), 339-344, 2009 | 115 | 2009 |
IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells C Menetrier-Caux, MC Thomachot, L Alberti, G Montmain, JY Blay Cancer research 61 (7), 3096-3104, 2001 | 110 | 2001 |
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage C Dezutter-Dambuyant, I Durand, L Alberti, N Bendriss-Vermare, ... Oncoimmunology 5 (3), e1091146, 2016 | 103 | 2016 |
KIT Mutations Induce Intracellular Retention and Activation of an Immature Form of the KIT Protein in Gastrointestinal Stromal Tumors S Tabone-Eglinger, F Subra, H El Sayadi, L Alberti, E Tabone, JP Michot, ... Clinical cancer research 14 (8), 2285-2294, 2008 | 97 | 2008 |
IL‐6 as an intracrine growth factor for renal carcinoma cell lines L Alberti, MC Thomachot, T Bachelot, C Menetrier‐Caux, I Puisieux, ... International journal of cancer 111 (5), 653-661, 2004 | 90 | 2004 |
Targeted cancer therapies JY Blay, A Le Cesne, L Alberti, I Ray-Coquart Bulletin du cancer 92 (2), 10013-10018, 2005 | 78 | 2005 |
Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study A Neuville, D Ranchère-Vince, AP Dei Tos, MC Montesco, I Hostein, ... The American journal of surgical pathology 37 (8), 1259-1268, 2013 | 77 | 2013 |
Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions B Dadone-Montaudié, L Alberti, A Duc, L Delespaul, T Lesluyes, G Pérot, ... Modern Pathology 31 (11), 1683-1693, 2018 | 74 | 2018 |
Filigree-like rete ridges, lobulated nests, rosette-like structures, and exaggerated maturation characterize Spitz tumors with NTRK1 fusion I Yeh, KJ Busam, TH McCalmont, PE LeBoit, D Pissaloux, L Alberti, ... The American journal of surgical pathology 43 (6), 737-746, 2019 | 71 | 2019 |
ET-743: a novel agent with activity in soft-tissue sarcomas J Fayette, IR Coquard, L Alberti, H Boyle, P Méeus, AV Decouvelaere, ... Current opinion in oncology 18 (4), 347-353, 2006 | 71 | 2006 |
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma … AL Giraudet, PA Cassier, C Iwao-Fukukawa, G Garin, JN Badel, D Kryza, ... BMC cancer 18, 1-13, 2018 | 64 | 2018 |
Cutaneous melanocytoma with CRTC1-TRIM11 fusion: report of 5 cases resembling clear cell sarcoma L Cellier, E Perron, D Pissaloux, M Karanian, V Haddad, L Alberti, ... The American journal of surgical pathology 42 (3), 382-391, 2018 | 60 | 2018 |
ET-743: a novel agent with activity in soft tissue sarcomas J Fayette, IR Coquard, L Alberti, D Ranchère, H Boyle, JY Blay The Oncologist 10 (10), 827-832, 2005 | 58 | 2005 |
Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model E Jouanneau, L Alberti, M Nejjari, I Treilleux, I Vilgrain, A Duc, ... Journal of neuro-oncology 51, 11-18, 2001 | 52 | 2001 |